Evidence map›Paper›PMID 30647080›Full record

Trial reportClinical cancer research : an official journal of the American Association for Cancer Research2019

Utility of Diffusion-weighted Imaging to Decrease Unnecessary Biopsies Prompted by Breast MRI: A Trial of the ECOG-ACRIN Cancer Research Group (A6702).

Habib Rahbar, Zheng Zhang, Thomas L Chenevert, Justin Romanoff, Averi E Kitsch, Lucy G Hanna, Sara M Harvey, Linda Moy, Wendy B DeMartini, Basak Dogan and 10 more

Registry-linked trialAbstract readClinical Trial, Phase IIMulticenter Study
In one paragraph

Trial report in Clinical cancer research : an official journal of the American Association for Cancer Research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07598084 (Artificial Intelligence Solution for Simplifying the Diagnostic Workflow of Breast MRI), which is not on this map. Cited by 69 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07598084 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Artificial Intelligence Solution for Simplifying the Diagnostic Workflow of Breast MRI: Development and Clinical Validation of a Diffusion-Weighted Imaging-Based Synthetic Contrast-Enhanced MRI System for Non-Contrast Breast Cancer Diagnosis and Risk Stratification

TypeobservationalSponsorPeking University People's HospitalRan2026 to 2027Enrolled12,000ConditionsBreast Neoplasms, Artificial Intelligence (AI), Magnetic Resonance Imaging (MRI), Diffusion Magnetic Resonance ImagingArmsNon-contrast breast MRI diagnostic model
3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Breast Diffusion-weighted MR Imaging: Current Applications, Insights from Screening, and Future Directions.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2025
    Review
  14. Article
  15. Review
  16. Article
  17. Quantitative MR Imaging of the Breast.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2025
    Review
  18. Article
  19. Article
  20. Non-contrast Breast MR Imaging.Radiologic clinics of North America · 2024
    Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Habib RahbarUniversity of Washington School of Medicine, Seattle, Washington. hrahbar@uw.edu.
Zheng ZhangCenter for Statistical Sciences, Brown University School of Public Health, Providence, Rhode Island.
Thomas L ChenevertUniversity of Michigan Medical School, Ann Arbor, Michigan.
Justin RomanoffCenter for Statistical Sciences, Brown University School of Public Health, Providence, Rhode Island.
Averi E KitschUniversity of Washington School of Medicine, Seattle, Washington.
Lucy G HannaCenter for Statistical Sciences, Brown University School of Public Health, Providence, Rhode Island.
Sara M HarveyVanderbilt University School of Medicine, Nashville, Tennessee.
Linda MoyNew York University School of Medicine, New York, New York.
Wendy B DeMartiniUniversity of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Basak DoganMD Anderson Cancer Center, Houston, Texas.
Wei T YangMD Anderson Cancer Center, Houston, Texas.
Lilian C WangNorthwestern University Feinberg School of Medicine, Chicago, Illinois.
Bonnie N JoeUniversity of California, San Francisco School of Medicine, San Francisco, California.
Karen Y OhOregon Health Sciences University, Portland, Oregon.
Colleen H NealUniversity of Michigan Medical School, Ann Arbor, Michigan.
Elizabeth S McDonaldUniversity of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Mitchell D SchnallUniversity of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Constance D LehmanMassachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Christopher E ComstockMemorial Sloan Kettering Cancer Center, New York, New York.
Savannah C PartridgeUniversity of Washington School of Medicine, Seattle, Washington.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Project-006U10CA180820 · NCI · ECOG-ACRIN MEDICAL RESEARCH FOUNDATION · PI Peter J ODwyer · 2014 to 2026
$167.6M
Statistics CoreU10CA180794 · NCI · DANA-FARBER CANCER INST · PI PAUL J CATALANO · 2014 to 2026
$111.2M
Network Lead Academic Participating Site: Memorial Sloan Kettering Cancer CenterUG1CA233290 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI CAROL AGHAJANIAN, Darren Feldman · 2019 to 2026
$10.2M
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)U10CA180858 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI HUNT, KELLY K, PINNIX, CHELSEA CAMILLE · 2014 to 2018
$5.6M
UM LAPs -UG1 GrantUG1CA233160 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANNE F SCHOTT · 2019 to 2026
$5.4M
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer CenterU10CA180791 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI AGHAJANIAN, CAROL, MORRIS, MICHAEL J · 2014 to 2018
$4.6M
Hutchinson Center as Lead Academic Participating Site (UG1)UG1CA233328 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Evan Yu · 2019 to 2026
$4.3M
Quantitative DW-MRI for Early Breast Cancer Treatment Response AssessmentU01CA166104 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHENEVERT, THOMAS L, GALBAN, CRAIG J · 2012 to 2019
$4.1M
UM LAPs- U10 GrantU10CA180801 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ZALUPSKI, MARK M · 2014 to 2018
$3.7M
Vanderbilt Network Lead Academic Participating Site for the NCTNUG1CA233270 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Kristen Keon Ciombor · 2019 to 2026
$3.5M
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10U10CA180870 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI GERBER, DAVID ERIC · 2014 to 2018
$3.4M
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA151326NCI NIH HHS R01 CA207290NCI NIH HHS U01 CA166104NCI NIH HHS U10 CA180791NCI NIH HHS U10 CA180794NCI NIH HHS U10 CA180799NCI NIH HHS U10 CA180801NCI NIH HHS U10 CA180816NCI NIH HHS U10 CA180820NCI NIH HHS U10 CA180828NCI NIH HHS U10 CA180847NCI NIH HHS U10 CA180858NCI NIH HHS U10 CA180870NCI NIH HHS UG1 CA233160NCI NIH HHS UG1 CA233270NCI NIH HHS UG1 CA233290NCI NIH HHS UG1 CA233328
6 · The paper itself

Abstract

purposeConventional breast MRI is highly sensitive for cancer detection but prompts some false positives. We performed a prospective, multicenter study to determine whether apparent diffusion coefficients (ADCs) from diffusion-weighted imaging (DWI) can decrease MRI false positives.

resultsOf 107 women enrolled, 67 patients (median age 49, range 24-75 years) with 81 lesions with confirmed reference standard (28 malignant, 53 benign) and evaluable DWI were analyzed. Sixty-seven of 81 lesions were BI-RADS 4 (

conclusionsDWI can reclassify a substantial fraction of suspicious breast MRI findings as benign and thereby decrease unnecessary biopsies. ADC thresholds identified in this trial should be validated in future phase III studies.

Indexed as

Image Interpretation, Computer-AssistedAdultAgedBiopsyBreastBreast NeoplasmsDiagnosis, DifferentialDiffusion Magnetic Resonance ImagingFalse Positive ReactionsFemaleHumansMiddle AgedProspective StudiesReference ValuesROC CurveSensitivity and Specificity

Identifiers

PMID30647080
PMCPMC6420847

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.